The Quintara decision: Defining trade secrets in federal cases

A notable Ninth Circuit ruling raises questions about disclosure that trade secrets plaintiffs will want to consider—particularly with regards to timing, says Carolyn Hoecker Luedtke of Munger, Tolles & Olson.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia

Trade secrets go global: How brand owners face a high-stakes battlefront

15 September 2025 How can companies stay ahead in trade secret protection, from adapting to new legislation and emerging case law to managing cross-border risks? Marisa Woutersen reports from the AIPPI World Congress 2025.

Europe

Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings

18 August 2025 Insulet and Masimo are among the parties that feature in this year’s one-of-a-kind rankings, courtesy of sister magazine WIPR, detailing the year’s most significant trade secrets matters around the world and who handled them.

Americas

Ninth Circuit revives trade secrets claims in DNA-sequencing spat

13 August 2025 Plaintiff accuses defendant of “locking” employees out of office to steal secrets | Ruling rejects California’s stricter “reasonable particularity” rule for federal DTSA cases | Decision may shape plaintiffs’ choice of legal claims in future disputes in the state.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

The Quintara decision: Defining trade secrets in federal cases

More on this story

Editor's picks

Editor's picks

More features